首页 | 本学科首页   官方微博 | 高级检索  
     


Vismodegib Efficacy in Advanced Basal Cell Carcinoma Maintained with 8-Week Dose Interruptions: A Model-Based Evaluation
Authors:Pascal Chanu  Luna Musib  Xin Wang  Sravanthi Cheeti  Sandhya Girish  Rene Bruno  Tong Lu  Josina Reddy  Jin Y. Jin  Ivor Caro
Affiliation:1. Department of Clinical Pharmacology, Genentech/Roche, Lyon, France;2. Department of Clinical Pharmacology, Genentech, Inc, South San Francisco, California, USA;3. Department of Clinical Pharmacology, Genentech/Roche, Marseille, France;4. Product Development Oncology, Genentech/Roche, South San Francisco, California, USA
Abstract:
Keywords:laBCC"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0015"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  locally advanced basal cell carcinoma  mBCC"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0025"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  metastatic basal cell carcinoma  TGI"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0035"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  tumor growth inhibition  TS"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0045"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  tumor size
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号